| DIRECT COMPETITOR COMPARISON | |
| ACET | Pvt1 | Pvt2 | Pvt3 | Industry | | Market Cap: | 127.86M | N/A | N/A | N/A | 122.77M | | Employees: | 221 | N/A | 41 | 4,4002 | 181 | | Qtrly Rev Growth (yoy): | -24.80% | N/A | N/A | N/A | 14.60% | | Revenue (ttm): | 299.42M | N/A | 400.00K1 | 4.30B2 | 31.21M | | Gross Margin (ttm): | 16.20% | N/A | N/A | N/A | 72.61% | | EBITDA (ttm): | 8.86M | N/A | N/A | N/A | -1.65M | | Oper Margins (ttm): | 2.28% | N/A | N/A | N/A | 2.37% | | Net Income (ttm): | 5.08M | N/A | N/A | N/A | N/A | | EPS (ttm): | 0.203 | N/A | N/A | N/A | N/A | | P/E (ttm): | 25.42 | N/A | N/A | N/A | 13.72 | | PEG (5 yr expected): | 0.82 | N/A | N/A | N/A | 2.18 | | P/S (ttm): | 0.43 | N/A | N/A | N/A | 3.27 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.08 | 0.00% | 57.77B | 12.45 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.84 | 0.00% | 13.84B | 16.01 | | Genzyme Corp. | GENZ | 51.11 | 0.00% | 13.56B | 29.14 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.40 | 0.00% | 41.76B | 17.94 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.76 | 0.00% | 9.05B | 1035.92 | | Teva Pharmaceutical Industries Limited | TEVA | 53.38 | 0.00% | 47.03B | 48.84 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.55 | 0.00% | 3.99B | 19.36 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.89 | 0.00% | 2.95B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.23 | 0.00% | 5.57B | 111.84 | | Pfizer Inc. | PFE | 18.85 | 0.00% | 152.11B | 15.66 | | Johnson & Johnson | JNJ | 63.51 | 0.00% | 175.23B | 13.87 | | GlaxoSmithKline plc | GSK | 42.41 | 0.00% | 107.51B | 13.51 | | Sanofi-Aventis | SNY | 39.32 | 0.00% | 102.67B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 56.16 | 0.00% | 127.55B | 16.81 | | RHHBY.PK | 41.40 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.74 | 0.00% | 66.32B | 9.18 | | Abbott Laboratories | ABT | 54.48 | 0.00% | 84.27B | 14.76 | | Bristol-Myers Squibb Co. | BMY | 24.65 | 0.00% | 48.83B | 12.75 |
|
| NEWS ON DIRECT COMPETITORS | | No News on Direct Competitors |
|
|